Get the Stockscreener App
9.10
1.34%
0.12
After Hours:
8.94
-0.16
-1.76%
Neogenomics Inc stock is traded at $9.10, with a volume of 4.14M.
It is up +1.34% in the last 24 hours and up +11.11% over the past month.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
See More
Previous Close:
$8.98
Open:
$9
24h Volume:
4.14M
Relative Volume:
1.60
Market Cap:
$1.18B
Revenue:
$628.25M
Net Income/Loss:
$-78.55M
P/E Ratio:
-14.68
EPS:
-0.62
Net Cash Flow:
$-29.73M
1W Performance:
+14.75%
1M Performance:
+11.11%
6M Performance:
+4.36%
1Y Performance:
-35.55%
1-Day Range:
$8.825
$9.17
1-Week Range:
$7.56
$9.17
52-Week Range:
$4.72
$19.11
Neogenomics Inc Stock (NEO) Company Profile
Name
Neogenomics Inc
Sector
Industry
Phone
(239) 768-0600
Address
9490 NEOGENOMICS WAY, FORT MYERS, FL
Compare NEO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
9.10 | 1.16B | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
543.32 | 198.23B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
214.99 | 150.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
631.19 | 50.71B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.64 | 39.32B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
206.63 | 34.74B | 15.70B | 1.24B | 2.01B | 6.9036 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-30-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-29-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-15-25 | Initiated | Guggenheim | Neutral |
| Apr-30-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jan-13-25 | Downgrade | The Benchmark Company | Buy → Hold |
| Dec-10-24 | Initiated | Jefferies | Buy |
| May-01-24 | Resumed | Craig Hallum | Buy |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Aug-21-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| May-16-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-09-23 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-24-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Feb-01-23 | Upgrade | Needham | Hold → Buy |
| Aug-26-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-22-22 | Downgrade | Needham | Buy → Hold |
| Jun-03-22 | Initiated | Piper Sandler | Overweight |
| Mar-29-22 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-29-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-18-22 | Resumed | Stephens | Overweight |
| Dec-16-21 | Initiated | Cowen | Outperform |
| Nov-05-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-14-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-25-21 | Resumed | Needham | Buy |
| Feb-25-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-28-21 | Initiated | Truist | Buy |
| Dec-11-20 | Resumed | BTIG Research | Buy |
| Oct-28-20 | Reiterated | Needham | Buy |
| Sep-09-20 | Initiated | Morgan Stanley | Overweight |
| Aug-28-20 | Initiated | Guggenheim | Buy |
| Jul-29-20 | Reiterated | Needham | Buy |
| Jun-25-20 | Initiated | BofA/Merrill | Buy |
| Apr-21-20 | Resumed | Stephens | Overweight |
| Mar-02-20 | Resumed | Craig Hallum | Buy |
| Feb-28-20 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jan-23-20 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-30-19 | Reiterated | Needham | Buy |
| May-01-19 | Reiterated | Needham | Buy |
| Mar-29-19 | Reiterated | Needham | Buy |
| Jan-03-19 | Initiated | Needham | Buy |
| Oct-24-18 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Aug-21-18 | Initiated | Leerink Partners | Outperform |
| May-02-18 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Sep-11-17 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-24-17 | Initiated | Gabelli & Co | Buy |
| Dec-15-16 | Initiated | Cantor Fitzgerald | Overweight |
View All
Neogenomics Inc Stock (NEO) Latest News
What catalysts could drive NeoGenomics Inc. stock higherJuly 2025 PreEarnings & Stock Portfolio Risk Control - newser.com
Is NeoGenomics Inc. (NG9) stock good for wealth creationTrade Exit Summary & Weekly High Return Forecasts - newser.com
What valuation multiples suggest for NeoGenomics Inc. stockPortfolio Value Summary & Low Drawdown Investment Ideas - newser.com
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know - The Globe and Mail
Strategies to average down on NeoGenomics Inc.2025 Earnings Surprises & Daily Entry Point Trade Alerts - newser.com
NeoGenomics (NASDAQ:NEO Shareholders Incur Further Losses as Stock Declines 7.5% This Week, Taking Five-year Losses to 79% - 富途牛牛
Opportunities in the Booming AI in Bioinformatics Market: A $26+ Billion Industry by 2029 Led by Thermo Fisher Scientific, Eurofins Scientific, Dassault Systemes, Illumina and NeoGenomics Laboratories - Yahoo Finance
NeoGenomics (NEO): Exploring Current Valuation After Recent Share Price Volatility - Yahoo Finance
Is NeoGenomics Inc a good long term investmentCurrency Fluctuation Impact & Small Capital Growth Stocks - earlytimes.in
NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
United States Clinical Laboratory Services Market Poised - openPR.com
Here’s Alger Weatherbie Specialized Growth Fund’s Comment on NeoGenomics (NEO) - Yahoo
NeoGenomics (NEO) Tops Q4 Earnings Estimates - MSN
Guidance Update: How does NeoGenomics Inc perform in inflationary periods2025 Technical Patterns & Safe Capital Growth Stock Tips - خودرو بانک
Sectors Review: Can FANG reach resistance levels soonMarket Volume Summary & Weekly Watchlist of Top Performers - khodrobank.com
Big Money Moves: What is NeoGenomics Inc. s debt to equity ratioTrade Analysis Report & AI Driven Price Predictions - خودرو بانک
Market Trends: Is Centerra Gold Inc. a turnaround storyRate Cut & AI Optimized Trade Strategies - khodrobank.com
Published on: 2025-09-19 15:28:49 - خودرو بانک
NeoGenomics (NASDAQ:NEO) Stock Price Down 3.8%Here's Why - MarketBeat
NeoGenomics rallies after court win in Natera patent dispute - MSN
Options Flow: Can Fenbo Holdings Limited scale operations efficientlyEarnings Performance Report & Smart Swing Trading Techniques - khodrobank.com
Market Outlook: Can NeoGenomics Inc keep up with sector leadersJuly 2025 Momentum & Breakout Confirmation Trade Signals - خودرو بانک
Risk Hedge: Why is NeoGenomics Inc. stock going up2025 Trade Ideas & Free Community Consensus Stock Picks - خودرو بانک
FOMO Trade: What is Gain Therapeutics Incs 5 year growth outlookJuly 2025 Movers & Low Risk High Reward Trade Ideas - khodrobank.com
TD Cowen Issues Positive Forecast for NeoGenomics (NASDAQ:NEO) Stock Price - MarketBeat
Can NeoGenomics Inc keep up with sector leadersMarket Activity Recap & Real-Time Volume Spike Alerts - خودرو بانک
Aug Gainers: What is NeoGenomics Incs 5 year growth outlook2025 Performance Recap & Free Technical Pattern Based Buy Signals - khodrobank.com
NeoGenomics (NASDAQ:NEO) Stock Price Up 8.5%Here's What Happened - MarketBeat
Weekly Trades: Is NeoGenomics Inc stock undervalued right nowQuarterly Performance Summary & Real-Time Stock Entry Alerts - خودرو بانک
Analyst Calls: Does NeoGenomics Inc. have a sustainable dividendQuarterly Trade Review & Growth Oriented Trade Recommendations - خودرو بانک
Sell Signal: Can NeoGenomics Inc stock outperform in a bear marketNew Guidance & Free Technical Confirmation Trade Alerts - خودرو بانک
Sectors Review: Why is NeoGenomics Inc stock going upEarnings Risk Summary & Consistent Growth Equity Picks - خودرو بانک
Is Network 1 Technologies Inc. forming bullish engulfing patternsPortfolio Growth Summary & Precise Buy Zone Tips - خودرو بانک
Bond Watch: Will NeoGenomics Inc stock hit new highs in YEARGlobal Markets & Growth Focused Entry Point Reports - خودرو بانک
RSI Check: Is NeoGenomics Inc stock a good pick for beginnersJuly 2025 News Drivers & Technical Buy Zone Confirmation - خودرو بانک
Volume Report: Should you buy the dip on NeoGenomics IncMarket Trend Report & Fast Entry and Exit Trade Plans - خودرو بانک
Bear Alert: Is NeoGenomics Inc forming bullish engulfing patterns2025 Top Decliners & Fast Moving Trade Plans - خودرو بانک
Exact Sciences’ Cancerguard™ Launch Could Be a Game Changer for NeoGenomics (NEO) - Sahm
Risk Off: Does BWMX meet Warren Buffett’s criteriaPortfolio Return Summary & Reliable Entry Point Alerts - خودرو بانک
Insider Buy: What is the Moat Score of Banzai International Inc2025 Volume Leaders & Weekly Momentum Stock Picks - خودرو بانک
Fred Alger Management LLC Reduces Holdings in NeoGenomics, Inc. $NEO - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc.NEO - FinancialContent
Intraday pattern recognizer results for NeoGenomics Inc.July 2025 Spike Watch & Growth Focused Stock Reports - Newser
Technical signs of recovery in NeoGenomics Inc.Earnings Growth Summary & Reliable Price Breakout Signals - Newser
Neogenomics stock price target raised to $12 by TD Cowen on new product outlook - Investing.com Canada
Applying sector rotation models to NeoGenomics Inc.Trade Entry Summary & Community Verified Watchlist Alerts - Newser
Has NeoGenomics Inc. found a price floorWeekly Profit Analysis & Weekly Chart Analysis and Trade Guides - Newser
Why NeoGenomics (NEO) Shares Are Falling Today - TradingView
Neogenomics Inc Stock (NEO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.01%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):